0HF3 Cencora, Inc.
313.80USD+2.40%Mkt Cap: —P/E: 38.261d ago
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…
Industry Peers
Health Care Providers & ServicesKey Statistics
Company
Market Cap—
Enterprise Value70.66B USD
Revenue (TTM)332.77B USD
Gross Profit13.18B USD
Net Income (TTM)2.62B USD
Revenue/Share1715.73 USD
Last Price313.80 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees47.0K
CountryGB
SectorHealthcare
IndustryHealth Care Providers & Services
ISIN—
Valuation
P/E (Trailing)38.26
P/E (Forward)—
PEG—
EV/EBITDA12.74
EV/Revenue0.21
P/S—
P/B19.28
EPS (TTM)8.20
EPS (Forward)—
52W Range
245.7750% of range381.28
52W High381.28 USD
52W Low245.77 USD
Profitability
Gross Margin3.96%
Oper. Margin1.41%
EBITDA Margin1.67%
Profit Margin0.79%
ROE96.87%
ROA3.56%
Growth
Revenue Growth5.10%
Earnings Growth11.90%
Cash Flow & Leverage
Operating CF4.82B USD
CapEx (TTM)—
FCF Margin0.61%
FCF Yield—
Net Debt11.65B USD
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity446.52
Current Ratio0.94
Quick Ratio0.48
Book Value/Sh15.99 USD
Cash/Share14.75 USD
Dividends
Fwd Div Rate—
Trail. Div Rate2.35 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.211.93M
Float180.25M
Insiders4.30%
Institutions99.63%
Technical
SMA 50227.22 (+38.1%)
SMA 200198.00 (+58.5%)
Beta0.57
S&P 52W Chg14.58%
Avg Vol (30d)1.24K
Avg Vol (10d)875
Technical Indicators
RSI (14)52.4
MACD-1.3923
MACD Signal-0.0229
MACD Hist.-1.3694
BB Upper334.36 USD
BB Middle315.30 USD
BB Lower296.24 USD
BB Width12.09%
ATR (14)10.41 USD
Vol Ratio (20d)5.11x